Prevalence of hepatic steatosis as assessed by controlled attenuation parameter (CAP) in subjects with metabolic risk factors in primary care. A population-based study.
Fabrellas N, Hernández R, Graupera I, Solà E, Ramos P, Martín N, Sáez G, Simón C, Pérez A, Graell T, Larrañaga A, Garcia M, de la Arada A, Juanola A, Coiduras A, Duaso I, Casado A, Martin J, Ginès M, Moreno N, Gema Perez A, Marti L, Bernat M, Sola M, Olivé C, Solé C, Ginès P.
Fabrellas N, et al. Among authors: gines p, gines m.
PLoS One. 2018 Sep 18;13(9):e0200656. doi: 10.1371/journal.pone.0200656. eCollection 2018.
PLoS One. 2018.
PMID: 30226889
Free PMC article.
Clinical Trial.